Zanetta C, Gasperini C, Amato MP, Centonze D, et al. Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective. J Neurol 2025;272:446.
PMID: 40481170